Brief: Ryvu Therapeutics FY Net Loss Narrows To 31.7 Mln Zlotys
March 16 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* FY NET LOSS OF 31.7 MILLION ZLOTYS VERSUS LOSS OF 44.3
MILLION
ZLOTYS YEAR AGO
* FY REVENUE 15.7 MILLION ZLOTYS VERSUS 3.8 MILLION ZLOTYS
YEAR
AGO
* FY OPERATING LOSS OF 35.7 MILLION ZLOTYS VERSUS LOSS OF
45.4
MILLION ZLOTYS YEAR AGO
Source text for Eikon: ID:nEMbrCzFna
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys